MacroLensNP नेपालीने Sign in Create accountSign up
Free · Life Insurance

PMLI Prabhu Mahalaxmi Life Insurance Limited

Rs 429.00 +1.60 (+0.37%) as of 2026-11-06 15:00:00
Open
420.00
High
429.00
Low
417.20
Prev. close
427.40
Volume
11,243
Turnover
48.23 lakh
Avg volume (30 d)
7,821
52-week low Rs 392.60
high Rs 543.60 -21.1% from the 52-week high

Prabhu Mahalaxmi Life Insurance Limited (PMLI) is listed on the Nepal Stock Exchange in the Life Insurance sector. Its share price is Rs 429.00 as of 6 November 2026, 21.1% below its 52-week high of Rs 543.60 and 9.3% above its 52-week low of Rs 392.60. It trades at a P/E of 60.6 on earnings per share of Rs 7.08, close to the Life Insurance sector's median P/E of 56.6.

PMLI paid a dividend in 3 of the last 3 fiscal years we track; the latest was 4.42% cash and 4.00% bonus for FY 2081/2082. Promoters hold 85% of the shares and the public 15%.

Key figures latest report 2082/2083 Q4

Market value
2,277 crore · 22.77 arba
Shares listed
53,077,939
Paid-up capital
530.78 crore · 5.31 arba
EPS (annualised)
Rs 7.08
P/E
60.6
Book value / share
Rs 116.58
P/B
3.68
ROE
8.1%
ROA
1.46%
Dividend yield
1.03%
Net profit (annualised)
37.56 crore
Reserves
–
Total assets
2,576 crore · 25.76 arba
Debt to equity
3.16

Quarter by quarter trailing 12 months at each quarter

QuarterEPSEPS growth (y/y)Net profitRevenueROE
2082/2083 Q4 7.08 +1.3% 37.56 crore 649.84 crore · 6.50 arba 6.2%
2082/2083 Q3 7.07 +1.9% 37.51 crore 610.39 crore · 6.10 arba 6.3%
2082/2083 Q2 6.05 -13.7% 32.13 crore 590.30 crore · 5.90 arba 5.5%
2082/2083 Q1 5.81 -21.4% 30.83 crore 560.97 crore · 5.61 arba 5.3%
2081/2082 Q4 6.98 +1.2% 37.07 crore 537.33 crore · 5.37 arba 6.5%
2081/2082 Q3 6.93 +2.6% 36.80 crore 489.08 crore · 4.89 arba 6.6%
2081/2082 Q2 7.01 +5.5% 37.23 crore 468.39 crore · 4.68 arba 6.9%
2081/2082 Q1 7.39 -2.4% 39.20 crore 442.79 crore · 4.43 arba 7.4%

Dividends

Fiscal yearBonusCashBook close
2081/20824.00% 4.42% 5 Jan 2026
2080/20818.00% 0.42% 30 May 2025
2079/208010.00% 0.53% 2 Oct 2024

Who owns it

Promoters 85% Public 15%
Public float
8,136,848 shares
Mutual funds hold
1.0% of the float
Promoter lock-in
–

Latest news

MacroLens analysis of PMLI

More on PMLI on the full desk The rating and verdict, fair value, dump risk and warning signs, the 12-month target, the buy / sell meter with every past signal, cornering and broker activity - the analysis behind every number above. Create an account - 7-day trial

Other Life Insurance companies

CompanyPriceTodayP/EP/BMarket value
NLIC Nepal Life Insurance Co. Ltd. 740.00 +0.14% 150.75.87 7,015 crore · 70.15 arba
LICN Life Insurance Co. Nepal 799.00 +0.26% 108.34.49 4,395 crore · 43.95 arba
NLICL National Life Insurance Co. Lt... 580.00 -0.17% 89.14.54 3,301 crore · 33.01 arba
HLI Himalayan Life Insurance Limit... 303.00 -0.10% 87.13.25 2,770 crore · 27.70 arba
RNLI Reliable Nepal Life Insurance... 446.00 -0.67% 39.83.00 2,318 crore · 23.18 arba
ALICL Asian Life Insurance Co. Limit... 422.20 -0.42% 53.53.51 2,217 crore · 22.17 arba
ILI IME Life Insurance Company Lim... 443.00 +0.07% 37.93.27 2,215 crore · 22.15 arba
CLI Citizen Life Insurance Company... 442.00 +0.34% 56.53.36 2,210 crore · 22.10 arba

Every Life Insurance company 14

Browse all NEPSE stocks by sector →

PMLI: common questions

What is the share price of PMLI today?

PMLI (Prabhu Mahalaxmi Life Insurance Limited) closed at Rs 429.00 as of 6 November 2026 on NEPSE.

Does PMLI pay dividends?

PMLI paid a dividend in 3 of the last 3 fiscal years we track; the latest was 4.42% cash and 4.00% bonus for FY 2081/2082.

What is the P/E ratio of PMLI?

It trades at a P/E of 60.6 on earnings per share of Rs 7.08, close to the Life Insurance sector's median P/E of 56.6.

Is PMLI a good buy?

This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - PMLI's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.

Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.